Table 2.
Characterization of additional malignancy detected on MRI.
Additional malignancies (n = 50) | |
---|---|
Tumor subtype | |
DCIS | 28 (56%) |
IDC | 18 (36%) |
ILC | 4 (8%) |
Tumor side | |
Ipsilateral | 37 (74%) |
Contralateral | 13 (26%) |
MRI finding | |
Mass | 37 (74%) |
Non-mass enhancement | 13 (26%) |
Histological diagnosis | |
MR guided biopsy | 23 (46%) |
US guided biopsy | 12 (24%) |
Localization for excision | 7 (14%) |
Mastectomy | 8 (16%) |